Joseph Todisco - 17 Jan 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Executive Officer, Director
Signature: /s/ Joseph Todisco
Issuer symbol: CRMD
Transactions as of: 17 Jan 2025
Net transactions value: -$291,800
Form type: 4
Filing time: 22 Jan 2025, 21:11:40 UTC
Previous filing: 14 Jan 2025
Next filing: 02 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+187,500	+61%	$0.000000	495,528	17 Jan 2025	Direct	F1
transaction	CRMD	Common Stock	Tax liability	$291,800	-23,977	-4.8%	$12.17	471,551	17 Jan 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units granted on 01/17/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Content

These shares represent restricted stock units granted on 01/17/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.